Browse All

Current Filters

CLEAR FILTER x

TITLE

Safety and Efficacy of Mesenchymal Stem Cell Therapy in Multiple System Atrophy: Systematic Review

Author:Elimam, Noon   Albarari, Shams   Shaalan, Yara   Elsheikh, Shazaa   A.Alzamar, Ainaa   Elmekkawi, Nourhan   Mogahed, Rahaf   Alghuweiri, Razan   N. Ibrahim, Sara   

Session Name:P8: Movement Disorders: Atypical and Secondary Parkinsonism 1  

Topic:Movement Disorders  

Program Number:P8.015  

Author Institution:Bogomolets National Medical University, Kyiv, Ukraine, Umm Al Quaine, Ukraine  Tbilisi State Medical University, Tbilisi, Georgia, Tbilisi, Georgia  Misr University for Science and Technology, 6th of October City, Egypt, 6th of October City, Egypt  Benha Faculty of Medicine, Benha, Egypt, Banha, Egypt  Palestinian medical complex, Faculty of Medicine, Al-Quds University, Palestine, Palestine  Zifta General Hospital, Egypt, Egypt  6th of October University, 6th of October city, Egypt, Egypt  Jordan University of Science and Technology, Irbid, Jordan, Jordan  Ahfad University for Women, Khartoum, Sudan , Sudan  

Pilot Trial Investigating the Effects of a Prebiotic Fiber Bar on the Gut-Brain-Axis of People with Parkinson’s Disease (PD)

Author:Smith, Morganne   Todd, Olivia   Edirisinghe, Indika   Burton-Freeman, Britt   

Session Name:P8: Movement Disorders: Parkinson's Disease Emerging Therapeutics 2  

Topic:Movement Disorders  

Program Number:P8.016  

Author Institution:Illinois Institute of Technology, IL  Sorridi Therapeutics, Northbrook, IL  Illinois Institute of Technology , IL  

Solengepras, A Novel GPR6-inhibitor, Shows Potential to Improve Sleep Disturbance in Parkinson’s Disease: Results from the ASCEND Phase Two Trial

Author:Sarva, Harini   Ellenbogen, Aaron   Chou, Kelvin   Isaacson, Stuart   Pahwa, Rajesh   Merchant, Shabbir Hussain   Sheehan, Tim   Diva, Ulysses   Brice, Nicola   Charles, Michelle   Vaidya, Sagar   Xu, Xiao   Dubow, Jordan   Kieburtz, Karl   Hauser, Robert   

Session Name:P8: Movement Disorders: Parkinson's Disease Emerging Therapeutics 2  

Topic:Movement Disorders  

Program Number:P8.017  

Author Institution:Weill Cornell Medical Center, New York, NY  Quest Research Institute, Farmington Hills, MI  University of Michigan Health, Department of Neurology, Ann Arbor, MI  Parkinson's Dis & Mov Dis Ctr of Boca Raton, Boca Raton, FL  University of Kansas Medical Center, Kansas City, KS  Beth Israel Deaconess Medical Center, Boston, MA  Beacon Biosignals, MA  U Diva Statistical Consulting, CA  Cerevance, United Kingdom  Clintrex, FL  Parkinson’s Disease and Movement Disorders Center, Department of Neurology, University of South Florida, Tampa, FL  

Peer Mentorship in Motion: Community Exercise for People with Parkinson’s Disease

Author:Kleinschmidt, Lina   Roberts, Meredith   Amara, Amy   

Session Name:P9: Movement Disorders: Care Models and Patient Perceptions in Movement Disorders 2  

Topic:Movement Disorders  

Program Number:P9.001  

Author Institution:University of Colorado Anschutz Medical Center, Aurora, CO  Parkinson's Pointe, CO  

Apraxia as a Catalyst of Freezing of Gait in Parkinson’s Disease: Insights From Longitudinal Models

Author:Luna-Rangel, Francisco A.   Pozo, Karen   Barajas Llamas, Erick Alejandro   Gonzalez Bedolla, Brenda   Gonzalez Aguilar, Kenny   Martinez-Ramirez, Daniel   

Session Name:P9: Movement Disorders: Parkinson's Disease Clinical Presentations and Diagnosis 1  

Topic:Movement Disorders  

Program Number:P9.001  

Author Institution:Tecnológico de Monterrey, Monterrey, Mexico  Tecnológico de Monterrey, MONTERREY, NUEVO LEON, Mexico  Tecnológico de Monterrey, Mexico  Tecnológico de Monterrey, San Pedro Garza Garcia, Nuevo León, Mexico  Tecnológico de Monterrey, San Pedro Garza Garcia, Mexico